Year archive

NurExone Biologic Inc — 2021 filings

All 21 regulatory filings released by NurExone Biologic Inc (NRX) in 2021, sourced directly from the official regulator.

21 Filings

2021 Period

2021 filings (21)

Filing	Released	Lang
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2021-08-31	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2021-08-31	English
Interim MD&A - English.pdf Interim / Quarterly Report	2021-08-31	English
Interim financial statements/report – English.pdf Interim / Quarterly Report	2021-08-31	English
Consent of qualified person (NI 43-101) - English.pdf Regulatory Filings	2021-08-12	English
Technical report (NI 43-101) - English.pdf Regulatory Filings	2021-08-12	English
52-109FV1 - Certification of annual filings - CEO (E).pdf Regulatory Filings	2021-05-22	English
52-109FV1 - Certification of annual filings - CFO (E).pdf Regulatory Filings	2021-05-22	English
Annual MD&A - English.pdf Regulatory Filings	2021-05-22	English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).pdf Regulatory Filings	2021-05-22	English
52-109F1R - Certification of refiled annual filings - CEO (E).pdf Regulatory Filings	2021-02-02	English
52-109F1R - Certification of refiled annual filings - CFO (E).pdf Regulatory Filings	2021-02-02	English
Annual MD&A (amended) - English.pdf Management Reports	2021-02-02	English
Material change report - English.pdf Regulatory Filings	2021-01-30	English
News release - English.pdf Regulatory Filings	2021-01-30	English
52-109F1R - Certification of refiled annual filings - CEO (E).pdf Regulatory Filings	2021-01-18	English
52-109F1R - Certification of refiled annual filings - CFO (E).pdf Regulatory Filings	2021-01-18	English
Annual MD&A (amended) - English.pdf Management Reports	2021-01-18	English
52-109F2R - Certification of refiled interim filings - CFO (E).pdf Regulatory Filings	2021-01-18	English
52-109F2R - Certification of refiled interim filings - CEO (E).pdf Regulatory Filings	2021-01-18	English
Interim financial statements/report (amended) - English.pdf Interim / Quarterly Report	2021-01-18	English